Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute-Reference-Cited by-同舟云学术

Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute

Published:2017-08-14 Issue:1 Volume:17 Page:
ISSN:1471-2490
Container-title:BMC Urology
language:en
Short-container-title:BMC Urol

Author:

Miyake Makito,Tanaka Nobumichi,Asakawa Isao,Hori Shunta,Morizawa Yosuke,Tatsumi Yoshihiro,Nakai Yasushi,Inoue Takeshi,Anai Satoshi,Torimoto Kazumasa,Aoki Katsuya,Hasegawa Masatoshi,Fujii Tomomi,Konishi Noboru,Fujimoto Kiyohide

Publisher

Springer Science and Business Media LLC

Subject

Urology,Reproductive Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12894-017-0251-1.pdf

Reference32 articles.

1. Saito S, Ito K, Yorozu A, Aoki M, Koga H, Satoh T, Ohashi T, Shigematsu N, Maruo S, Kikuchi T, Kojima S, Dokiya T, Fukushima M, Yamanaka H. Nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implant (J-POPS). Int J Clin Oncol. 2015;20:375–85.

2. Tanaka N, Asakawa I, Hasegawa M, Fujimoto K. Urethral toxicity after LDR brachytherapy: experience in Japan. Brachytherapy. 2015;14:131–5.

3. Tanaka N, Fujimoto K, Hirayama A, Samma S, Momose H, Kaneko Y, Haramoto M, Hayashi Y, Nakagawa Y, Otani T, Watanabe S, Hirao Y. The primary therapy chosen for patients with localized prostate cancer between the university hospital and its affiliated hospitals in Nara Uro-Oncological research group registration. BMC Urol. 2011;11:6.

4. Lehrer S, Cesaretti J, Stone NN, Stock RG. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implant. BJU Int. 2006;98:979–81.

5. Tanaka N, Fujimoto K, Hirao Y, Asakawa I, Hasegawa M, Konishi N. Variations in international prostate symptom scores, uroflowmetric parameters, and prostate volume after 125I permanent brachytherapy for localized prostate cancer. Urology. 2009;74:407–11.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Duration of α-1 adrenergic antagonist administration after low-dose-rate brachytherapy for prostate cancer;Japanese Journal of Clinical Oncology;2024-08-28

2. Urinary tract symptoms that should be improved to enhance post-operative urinary quality of life in patients treated with low-dose-rate brachytherapy for prostate cancer: An importance–performance analysis;Journal of Contemporary Brachytherapy;2024

3. Chronological Changes of Lower Urinary Tract Symptoms in Elderly Patients with Prostate Cancer after Low-Dose-Rate Prostate Brachytherapy;Life;2023-07-04

4. Associations of Clinical and Dosimetric Parameters with Urinary Toxicities after Prostate Brachytherapy: A Long-Term Single-Institution Experience;Current Oncology;2023-06-09

5. Prostate diseases and microbiome in the prostate, gut, and urine;Prostate International;2022-06